{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:47:47Z","timestamp":1777351667840,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","plefa.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.plefa.2025.102685","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T10:54:06Z","timestamp":1748084046000},"page":"102685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Dysfunction of COX-2\/mPGES-1\/PGE2 pathway and EP4 receptor in bronchi from COPD patients"],"prefix":"10.1016","volume":"206","author":[{"given":"Salma","family":"Mani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhipeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hichem","family":"Badji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaelle","family":"Merheb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Castier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Thibaudeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathilde","family":"Varret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Guyard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Longrois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0734-3359","authenticated-orcid":false,"given":"Xavier","family":"Norel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2025.102685_bib0001","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1038\/s41598-024-53387-4","article-title":"Association of dietary niacin intake with the prevalence and incidence of chronic obstructive pulmonary disease","volume":"14","author":"Li","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.plefa.2025.102685_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155148","article-title":"Anti-inflammatory effects of adiponectin in cigarette smoke-activated alveolar macrophage through the COX-2\/PGE2 and TLRs signaling pathway","volume":"133","author":"Wang","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.plefa.2025.102685_bib0003","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Mortality and causes of death collaborators, global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"385","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.plefa.2025.102685_bib0004","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1183\/09031936.06.00025805","article-title":"Chronic obstructive pulmonary disease: current burden and future projections","volume":"27","author":"Lopez","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.plefa.2025.102685_bib0005","doi-asserted-by":"crossref","first-page":"e883","DOI":"10.1016\/S2214-109X(19)30172-X","article-title":"The escalating global burden of serious health-related suffering: projections to 2060 by world regions, age groups, and health conditions","volume":"7","author":"Sleeman","year":"2019","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.plefa.2025.102685_bib0006","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.3390\/ijms19113285","article-title":"Arachidonic acid metabolites in cardiovascular and metabolic diseases","volume":"19","author":"Sonnweber","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.plefa.2025.102685_bib0007","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","article-title":"Cyclooxygenases: structural, cellular, and molecular biology","volume":"69","author":"Smith","year":"2000","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.plefa.2025.102685_bib0008","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.1016\/S0021-9258(19)43558-8","article-title":"On the organization and mechanism of prostaglandin synthetase","volume":"248","author":"Wlodawer","year":"1973","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plefa.2025.102685_bib0009","doi-asserted-by":"crossref","first-page":"L391","DOI":"10.1152\/ajplung.00062.2005","article-title":"The aryl hydrocarbon receptor is a regulator of cigarette smoke induction of the cyclooxygenase and prostaglandin pathways in human lung fibroblasts","volume":"289","author":"Martey","year":"2005","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.plefa.2025.102685_bib0010","doi-asserted-by":"crossref","first-page":"L981","DOI":"10.1152\/ajplung.00239.2003","article-title":"Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E 2 synthase in human lung fibroblasts: implications for lung inflammation and cancer","volume":"287","author":"Martey","year":"2004","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.plefa.2025.102685_bib0011","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.it.2003.11.001","article-title":"The lung as a privileged site for the beneficial actions of PGE2","volume":"25","author":"Vancheri","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.plefa.2025.102685_bib0012","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.freeradbiomed.2009.10.047","article-title":"Induction of COX-2\/PGE2\/IL-6 is crucial for cigarette smoke extract-induced airway inflammation: role of TLR4-dependent NADPH oxidase activation","volume":"48","author":"Lin","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.plefa.2025.102685_bib0013","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1164\/rccm.201208-1361OC","article-title":"The cyclooxygenase-2\u2013Prostaglandin E 2 pathway maintains senescence of chronic obstructive pulmonary disease fibroblasts","volume":"187","author":"Dagouassat","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.plefa.2025.102685_bib0014","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.1074\/jbc.R600038200","article-title":"Prostaglandin E receptors","volume":"282","author":"Sugimoto","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2025.102685_bib0015","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1124\/pr.120.019331","article-title":"International Union of Basic and Clinical Pharmacology. CIX. Differences and similarities between Human and rodent prostaglandin E2 receptors (EP1-4) and prostacyclin receptor (IP): specific roles in pathophysiologic conditions","volume":"72","author":"Norel","year":"2020","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.plefa.2025.102685_bib0016","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1476-5381.2012.02189.x","article-title":"PGE2 maintains the tone of the guinea pig trachea through a balance between activation of contractile EP receptors and relaxant EP receptors","volume":"168","author":"S\u00e4fholm","year":"2013","journal-title":"Br. J. Pharmacol"},{"key":"10.1016\/j.plefa.2025.102685_bib0017","doi-asserted-by":"crossref","unstructured":"J. Buckley, M.A. Birrell, S.A. Maher, A.T. Nials, D.L. Clarke, M.G. Belvisi, EP4 receptor as a new target for bronchodilator therapy, Thorax 66 (2011) 1029\u20131035. https:\/\/doi.org\/10.1136\/thx.2010.158568.","DOI":"10.1136\/thx.2010.158568"},{"key":"10.1016\/j.plefa.2025.102685_bib0018","doi-asserted-by":"crossref","unstructured":"C. Benyahia, I. Gomez, L. Kanyinda, K. Boukais, C. Danel, G. Les\u00e9che, D. Longrois, X. Norel, PGE(2) receptor (EP(4)) agonists: potent dilators of human bronchi and future asthma therapy? Pulm Pharmacol Ther 25 (2012) 115\u2013118. https:\/\/doi.org\/10.1016\/j.pupt.2011.12.012.","DOI":"10.1016\/j.pupt.2011.12.012"},{"key":"10.1016\/j.plefa.2025.102685_bib0019","doi-asserted-by":"crossref","unstructured":"J. S\u00e4fholm, M.L. Manson, J. Bood, I. Delin, A.-C. Orre, P. Bergman, M. Al-Ameri, S.-E. Dahl\u00e9n, M. Adner, Prostaglandin E2 inhibits mast cell\u2013dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor, J. Allergy Clin. Immunol. 136 (2015) 1232\u20131239.e1. https:\/\/doi.org\/10.1016\/j.jaci.2015.04.002.","DOI":"10.1016\/j.jaci.2015.04.002"},{"key":"10.1016\/j.plefa.2025.102685_bib0020","doi-asserted-by":"crossref","unstructured":"Y.-C. Wu, L.-J. Su, H.-W. Wang, C.-F.Jeff Lin, W.-H. Hsu, T.-Y. Chou, C.-Y.F. Huang, C.-L. Lu, C.-T. Hsueh, Co-overexpression of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 adversely affects the postoperative survival in non-small cell lung cancer, J. Thorac. Oncol. 5 (2010) 1167\u20131174. https:\/\/doi.org\/10.1097\/JTO.0b013e3181e2f4f5.","DOI":"10.1097\/JTO.0b013e3181e2f4f5"},{"key":"10.1016\/j.plefa.2025.102685_bib0021","doi-asserted-by":"crossref","unstructured":"S. Thor\u00e9n, P.-J. Jakobsson, Coordinate up- and down-regulation of glutathione-dependent prostaglandin E synthase and cyclooxygenase-2 in A549 cells, Eur. J. Biochem. 267 (2000) 6428\u20136434. https:\/\/doi.org\/10.1046\/j.1432-1327.2000.01735.x.","DOI":"10.1046\/j.1432-1327.2000.01735.x"},{"key":"10.1016\/j.plefa.2025.102685_bib0022","doi-asserted-by":"crossref","unstructured":"G. Ozen, C. Benyahia, S. Mani, K. Boukais, A.M. Silverstein, R. Bayles, A.C. Nelsen, Y. Castier, C. Danel, H. Mal, L.H. Clapp, D. Longrois, X. Norel, Bronchodilation induced by PGE2 is impaired in group III pulmonary hypertension, Br. J. Pharmacol 177 (2020) 161\u2013174. https:\/\/doi.org\/10.1111\/bph.14854.","DOI":"10.1111\/bph.14854"},{"key":"10.1016\/j.plefa.2025.102685_bib0023","doi-asserted-by":"crossref","unstructured":"S. Togo, O. Holz, X. Liu, H. Sugiura, K. Kamio, X. Wang, S. Kawasaki, Y. Ahn, K. Fredriksson, C.M. Skold, K.C. Mueller, D. Branscheid, L. Welker, H. Watz, H. Magnussen, S.I. Rennard, Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanisms, Am J Respir Crit Care Med 178 (2008) 248\u2013260. https:\/\/doi.org\/10.1164\/rccm.200706-929OC.","DOI":"10.1164\/rccm.200706-929OC"},{"key":"10.1016\/j.plefa.2025.102685_bib0024","doi-asserted-by":"crossref","unstructured":"A. Bonanno, G.D. Albano, L. Siena, A.M. Montalbano, L. Riccobono, G. Anzalone, G. Chiappara, R. Gagliardo, M. Profita, A. Sala, Prostaglandin E2 possesses different potencies in inducing vascular Endothelial Growth Factor and Interleukin-8 production in COPD human lung fibroblasts, Prostaglandins Leukot. Essent. Fat. Acids 106 (2016) 11\u201318. https:\/\/doi.org\/10.1016\/j.plefa.2016.01.005.","DOI":"10.1016\/j.plefa.2016.01.005"},{"key":"10.1016\/j.plefa.2025.102685_bib0025","doi-asserted-by":"crossref","unstructured":"M. Murakami, K. Nakashima, D. Kamei, S. Masuda, Y. Ishikawa, T. Ishii, Y. Ohmiya, K. Watanabe, I. Kudo, Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2, J. Biol. Chem. 278 (2003) 37937\u201337947. https:\/\/doi.org\/10.1074\/jbc.M305108200.","DOI":"10.1074\/jbc.M305108200"},{"key":"10.1016\/j.plefa.2025.102685_bib0026","doi-asserted-by":"crossref","unstructured":"M. Camacho, E. Gerbol\u00e9s, J.-R. Escudero, R. Ant\u00f3n, X. Garc\u00eda-Moll, L. Vila, Microsomal prostaglandin E synthase-1, which is not coupled to a particular cyclooxygenase isoenzyme, is essential for prostaglandin E(2) biosynthesis in vascular smooth muscle cells, J. Thromb. Haemost.: JTH 5 (2007) 1411\u20131419. https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02555.x.","DOI":"10.1111\/j.1538-7836.2007.02555.x"},{"key":"10.1016\/j.plefa.2025.102685_bib0027","doi-asserted-by":"crossref","unstructured":"L.J. Kay, W.W. Yeo, P.T. Peachell, Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation, Br, J. Pharmacol 147 (2006) 707\u2013713. https:\/\/doi.org\/10.1038\/sj.bjp.0706664.","DOI":"10.1038\/sj.bjp.0706664"},{"key":"10.1016\/j.plefa.2025.102685_bib0028","doi-asserted-by":"crossref","unstructured":"T.V. Hartert, R.T. Dworski, B.G. Mellen, J.A. Oates, J.J. Murray, J.R. Sheller, Prostaglandin E 2 decreases allergen-stimulated release of Prostaglandin D 2 in airways of subjects with asthma, Am J Respir Crit Care Med 162 (2000) 637\u2013640. https:\/\/doi.org\/10.1164\/ajrccm.162.2.9904038.","DOI":"10.1164\/ajrccm.162.2.9904038"},{"key":"10.1016\/j.plefa.2025.102685_bib0029","doi-asserted-by":"crossref","unstructured":"J. Qiu, Q. Li, J. Li, F. Zhou, P. Sang, Z. Xia, W. Wang, L. Wang, Y. Yu, J. Jiang, Complementary roles of EP2 and EP4 receptors in malignant glioma, Br J Pharmacol 180 (2023) 2623\u20132640. https:\/\/doi.org\/10.1111\/bph.16148.","DOI":"10.1111\/bph.16148"},{"key":"10.1016\/j.plefa.2025.102685_bib0030","doi-asserted-by":"crossref","unstructured":"A. Kourpa, A. Schulz, E. Mangelsen, D. Kaiser-Graf, N. Koppers, M. Stoll, M. Rothe, M. Bader, B. Purf\u00fcrst, S. Kunz, T. Gladytz, T. Niendorf, S. Bachmann, K. Mutig, J. Bolbrinker, D. Pan\u00e1kov\u00e1, R. Kreutz, Studies in zebrafish and rat models support dual blockade of EP2 and EP4 (Prostaglandin E2 Receptors Type 2 and 4) for renoprotection in glomerular hyperfiltration and albuminuria, Hypertension 80 (2023) 771\u2013782. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.122.20392.","DOI":"10.1161\/HYPERTENSIONAHA.122.20392"},{"key":"10.1016\/j.plefa.2025.102685_bib0031","doi-asserted-by":"crossref","unstructured":"H. Aso, S. Ito, A. Mori, N. Suganuma, M. Morioka, N. Takahara, M. Kondo, Y. Hasegawa, Differential regulation of airway smooth muscle cell migration by E-prostanoid receptor subtypes, Am J Respir Cell Mol Biol 48 (2013) 322\u2013329. https:\/\/doi.org\/10.1165\/rcmb.2012-0158OC.","DOI":"10.1165\/rcmb.2012-0158OC"},{"key":"10.1016\/j.plefa.2025.102685_bib0032","doi-asserted-by":"crossref","unstructured":"P. Luschnig-Schratl, E.M. Sturm, V. Konya, S. Philipose, G. Marsche, E. Fr\u00f6hlich, C. Samberger, D. Lang-Loidolt, S. Gattenl\u00f6hner, I.Th. Lippe, B.A. Peskar, R. Schuligoi, A. Heinemann, EP4 receptor stimulation down-regulates human eosinophil function, Cell, Mol, Life Sci 68 (2011) 3573\u20133587. https:\/\/doi.org\/10.1007\/s00018-011-0642-5.","DOI":"10.1007\/s00018-011-0642-5"},{"key":"10.1016\/j.plefa.2025.102685_bib0033","doi-asserted-by":"crossref","unstructured":"M.A. Birrell, S.A. Maher, B. Dekkak, V. Jones, S. Wong, P. Brook, M.G. Belvisi, Anti-inflammatory effects of PGE2 in the lung: role of the EP4 receptor subtype, Thorax 70 (2015) 740\u2013747. https:\/\/doi.org\/10.1136\/thoraxjnl-2014-206592.","DOI":"10.1136\/thoraxjnl-2014-206592"},{"key":"10.1016\/j.plefa.2025.102685_bib0034","doi-asserted-by":"crossref","unstructured":"S. Mukherjee, W. Sheng, A. Michkov, K. Sriarm, R. Sun, A. Dvorkin-Gheva, P.A. Insel, L.J. Janssen, Prostaglandin E 2 inhibits profibrotic function of human pulmonary fibroblasts by disrupting Ca 2+ signaling, Am. J. Physiol.-Lung Cell. Mol. Physiol. 316 (2019) L810\u2013L821. https:\/\/doi.org\/10.1152\/ajplung.00403.2018.","DOI":"10.1152\/ajplung.00403.2018"},{"key":"10.1016\/j.plefa.2025.102685_bib0035","doi-asserted-by":"crossref","unstructured":"E. Reiter, R.J. Lefkowitz, GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling, Trends Endocrinol Metab 17 (2006) 159\u2013165. https:\/\/doi.org\/10.1016\/j.tem.2006.03.008.","DOI":"10.1016\/j.tem.2006.03.008"},{"key":"10.1016\/j.plefa.2025.102685_bib0036","doi-asserted-by":"crossref","unstructured":"S. Desai, H. April, C. Nwaneshiudu, B. Ashby, Comparison of agonist-induced internalization of the human EP2 and EP4 prostaglandin receptors: role of the carboxyl terminus in EP4 receptor sequestration, Mol Pharmacol 58 (2000) 1279\u20131286. https:\/\/doi.org\/10.1124\/mol.58.6.1279.","DOI":"10.1124\/mol.58.6.1279"},{"key":"10.1016\/j.plefa.2025.102685_bib0037","doi-asserted-by":"crossref","unstructured":"C. K\u00f6nig, A. Ebersberger, A. Eitner, R. Wetzker, H.-G. Schaible, Prostaglandin EP3 receptor activation is antinociceptive in sensory neurons via PI3K\u03b3, AMPK and GRK2, Br J Pharmacol 180 (2023) 441\u2013458. https:\/\/doi.org\/10.1111\/bph.15971.","DOI":"10.1111\/bph.15971"}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327825000225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327825000225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T10:45:31Z","timestamp":1756982731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327825000225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":37,"alternative-id":["S0952327825000225"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2025.102685","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysfunction of COX-2\/mPGES-1\/PGE2 pathway and EP4 receptor in bronchi from COPD patients","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins, Leukotrienes and Essential Fatty Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plefa.2025.102685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102685"}}